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ABSTRACT 
Drug utilization research is an important part of pharmacoepidemiology as it explains the extent, nature and determinants of drug exposure. A 
drug utilization study is a tool for determining the effectiveness of drug use. They have tendency to create sound economic bases for health care. 
It focuses on various factors related to prescribing, dispensing, and administration of medication and associated events. It is a study which is 
used for analyzing or describe-quantitatively and qualitatively- the population of users of a given drug (or class of drug) and/or the condition of 
use (for example, indication, duration of treatment, dosage, previous or associated treatment and compliance). ENT problems have been counted 
as prominent as well as commonly occurring medical problem for our society. It is a problem of most concern. Drug utilization studies can play a 
major role to identify the nature of therapy used in their treatment and also helps to promote the rationality and minimizing the errors in the 
drug therapy. Such kind of studies can be helpful for healthcare practitioners as well as to the society against such health issues. Drug utilization 
research developed quickly during the following 30 years and soon became a respectable subject for consideration at international congresses in 
pharmacology, pharmacy and epidemiology. Successful research in drug requires multidisciplinary collaboration between clinicians, clinical 
pharmacologists, pharmacists and epidemiologists. Without the support of the prescribers, this research effort will fail to reach its goal of 
facilitating the rational use of drugs. In this review, we will briefly list various Drug utilization studies in ENT Clinical settings. 
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INTRODUCTION 
Drug utilization research is an important part of 
pharmacoepidemiology as it explains the extent, nature and 
determinants of drug exposure. A drug utilization study is a 
tool for determining the effectiveness of drug use. They have 
tendency to create sound economic bases for health care. It 
focuses on various factors related to prescribing, dispensing, 
and administration of medication and associated events. It is 
a study which is used for analyzing or describe-
quantitatively and qualitatively- the population of users of a 
given drug (or class of drug) and/or the condition of use (for 
example, indication, duration of treatment, dosage, previous 
or associated treatment and compliance) 1, 2, 3. 
WHY DRUG UTILIZATION STUDIES ARE NEEDED IN 
ENT? 
ENT is a medical abbreviation for ears, nose, and throat. A 
rotation in ear, nose and throat is becoming increasingly 
common in general practice. Some of the common disorders 
include, blocked nose or nasal discharge, ear pain, ear 
discharge, tender swelling behind the ear, sore throat, 
allergic rhinitis, otitis media and mastoiditis4.Rhinitis and 
sinusitis are among the most common medical condition. In 
Western societies an estimated 10% to 25% of the 
populations have allergic rhinitis, with 30 to 60 million 
persons being affected annually in the United States. Both 
Sinusitis and rhinitis can significantly decrease the quality of 
life and aggravate co-morbid conditions. Although mainstay 
of management of acute bacterial sinusitis is antibiotics, 
treatment of chronic sinusitis is less straight forward 
because only some chronic sinusitis has infectious basis5. 
Otitis media is the inflammation of the mucous membrane of 
the middle ear cleft which includes the middle ear cavity 
(tympanic cavity), mastoid antrum, mastoid air cells and the 
Eustachian tube. When the inflammation is associated with a 
discharge from the ear through a perforation in the tympanic 
membrane, suppurative (or discharging) otitis media occurs. 
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It may be acute (<6 weeks) or chronic (>6 weeks). It is one of 
the most common infectious diseases of childhood 
worldwide. Two out of three children will have at least one 
episode of otitis media before their third birthday. Varying 
prevalence rates of otitis media have been documented from 
various parts of the world. Infants and young children are at 
highest risk of developing otitis media, with peak prevalence 
between 6 and 36 months of age. It is particularly prevalent 
among children with cleft palate and other craniofacial 
defects, and those from lower socio-economic status. 
Bacteria have remained the most important etiological 
agents in suppurative or discharging otitis media. Resistance 
to multiple antibiotics is not uncommon, further 
predisposing to complications among affected children6. ENT 
related problems are common in the population and 
comprises up to 20% of adult and 40% of pediatric consults 
of a general practitioner. In adults, external ear problems, 
especially wax, are the most common reason for attendance. 
Otitis media is the commonest presentation in ages 0-4 
years, falling in older children, and hay fever affects around 1 
in 10. Diseases of ear, nose and throat can have serious 
consequences including hearing impairment, and emotional 
strain that lower the quality of life patients4. The vast 
majority of ENT problems that present in the pre hospital 
setting are minor in nature. However, occasionally 
innocuous symptoms can develop into life threatening 
conditions that require immediate assessment and 
treatment. ENT conditions can be immediately life 
threatening by causing an A, B, C problem. 
A. Airway obstruction which comprises inhaled foreign 
body, epiglottitis, anaphylaxis/angioedema, croup, facial 
fractures. 
B. Breathing difficulty due to croup, inhaled foreign body. 
C. Circulatory problems which includes hemorrhage due to 
epistaxis, from facial fractures, secondary hemorrhage 
after ENT surgery, e.g. after tonsillectomy7. 
Guidelines for appropriate management are widely available 
but not always followed. In appropriate referrals to 
secondary care increase waiting times, can be harmful and 
inconvenient to patients. It has been envisaged that with 
increase in global population, infections remain the most 
important causes of diseases, with upper respiratory 
infections causing hearing loss and learning disability 
particularly in children. Ear infections, such as otitis media 
have serious consequences in developing countries, such as 
retarded language development and poor progress in school 
children. Otitis media, which is now known to be the most 
common childhood infection, leads annually to the death of 
over 50,000 children under 5 years of age. In most 
developing countries the number of otolaryngologist is 
negligible, while the problem is complicated by the fact that 
there is no training for public health otolaryngology and 
other ENT related otolaryngology personnel. Diseases of the 
ear, nose and throat can be caused by a variety of 
microorganisms. Rhinoviruses are the leading cause for 
common cold in all age groups. Acute pharyngitis/ nostilitis 
are mainly associated with respiratory viruses, although 
bacteria, especially streptococcus are found in some patients. 
It has been shown that the nose is the main ecological niche 
where some of the drug resistant microorganisms like 
Staphylococcus aureus reside. Although acute otitis media is 
caused by bacteria the leading one being Streptococcus 
pneumonia, viral infections are a predisposing factor for its 
development. Although antibiotics have contributed to the 
control of ENT infections, their overuse and misuse is now 
seen to cause an increase in antibiotic resistance. Some of the 
chronic sinus ENT diseases resistant to current antibiotics 
include chronic middle ear infections, chronic sinus diseases, 
chronic coughs and recurrent pharyngo-tonsillitis. There is 
need to investigate means of developing new, efficacious 
drugs4. 
DRUG UTILIZATION STUDIES IN ENT TREATMENTS 
Various studies have been carried out with respect to drug 
utilization studies in ENT clinical settings. Sathiya SB et al. 
(2016) carried out prospective observational drug 
utilization at otorhinolaryngology department for a period of 
4 months. Out of 155 patients, the average number of drugs 
per patient was 1.2. The percentage of drugs prescribed with 
the generic name was 26.32%. During this study, it was 
found that the most commonly prescribed groups of 
antimicrobials were penicillins (34.87%) followed by 
fluroqinolones (26.32%) and nitroimidazole (25%). During 
the study, it was observed that 46.71% patients visited for 
treating ear infections, 12.5% for nasal infections and 
40.79% for throat infections. The routes of administration 
were oral (74.23%) and topical (20.10%). The study showed 
some rational prescription patterns like less utilization of 
antimicrobials in ENT infections and was according to 
standard treatment guideline. The results of this study will 
be useful in future for making standard treatment guidelines. 
It also promotes the rational prescription and rational use of 
drugs 8.  Nitasha GM et al. (2015), scrutinized the outpatient 
department (OPD) records of 608 patients with ENT 
infections, reporting to the ENT OPD of Justice K S Hegde 
Charitable Hospital, Deralakatte, Mangalore, over a period of 
1-year. Descriptive analysis of the data was done. Of the total 
608 prescriptions analyzed, 309 (50.8%) belonged to male 
patients and 299 (49.2%) belonged to female patients. 
Highest numbers of patients were in the age group of 16-25 
years (29.44%). The most common diseases reported were 
chronic suppurative otitis media (19.24%), followed by otitis 
externa (13.49%) and furunculosis (9.87%). Average 
number of drugs per prescription was found to be 3.0. Oral 
antibiotics were prescribed to 540 patients (88.81%). Most 
common antibiotics prescribed were amoxicillin-clavulanate 
(53%), levofloxacin (17%), and cefixime (14%). 
Antihistamines were prescribed in 52.47% prescriptions, 
and non-steroidal anti-inflammatory drugs were prescribed 
to 298 patients (49.01%). By this study they concluded that 
the diseases were treated rationally in accordance with the 
standard guidelines of therapy 9. Ilechukwu GC et al. 
(2014) studied otitis media in children and concluded that 
the treatment regimens for Acute Otitis Media (AOM) are 
controversial and continuously changing likely due to the 
increasing prevalence of resistant organisms. Accelerated 
patterns of bacterial resistance therefore, mandate an 
evidence-based approach to managing otitis media. There is 
wide variation in the use of antibiotics among doctors 
worldwide. The recommended treatment duration for 
uncomplicated AOM is 5 - 7 days. Amoxicillin has been the 
first line antibiotic for treating otitis media, even with a high 
prevalence of drug-resistant Streptococcus pneumoniae, 
because resistance to β-lactam antibiotics, such as 
amoxicillin, develops as a stepwise process. Amoxicillin-
clavulanate combination is an appropriate choice as a 
second-line antibiotic if a child is not responding to 
treatment after 72 hours on amoxicillin. The addition of 
clavulanate to amoxicillin will broaden the coverage while 
retaining efficacy against Streptococcus pneumoniae. Other 
appropriate choices include erythromycin combined with a 
sulphonamide; trimethoprim-sulfamethoxazole, cefaclor, 
cefuroxime axetil or cefixime. If the patient is allergic to the 
penicillins, the combination of oral erythromycin and 
sulfonamides is an alternative. Combined trimethoprim-
sulfamethoxazole can also be given to penicillin-sensitive 
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individuals.A child that remains symptomatic for more than 
three days while on a second-line agent requires 
tympanocentesis to identify the causative pathogen. If a 
highly resistant pneumococcus is found or if 
tympanocentesis is not feasible, clindamycin or 
intramuscular ceftriaxone appears to the best third-line 
agents. Recent studies have shown that short courses (2 - 3 
days of antibiotic) at conventional or high doses are equally 
effective in terms of resolution of symptoms and signs 6. 
Kalpana S et al. (2014), studied that ENT related diseases 
form a significant portion of ailments in pediatric age group 
in a hospital based study. Many of them present in 
emergency clinics with symptoms requiring urgent 
management. A prospective study was carried out in Gauhati 
Medical College, in patients below 16 years of age, to 
determine the hospital prevalence of ENT emergencies in 
pediatric age group and their management protocol as 
followed in a tertiary center. Emergencies relating to ear 
were most common followed by nasal and 
pahryngoesophageal conditions. Foreign bodies were most 
common among aural and nasal emergencies. A considerable 
number of patients presented with faciomaxillary and 
orodental injuries. Although mortality is low in such 
emergencies group, morbidity may be very high at times. In 
management of such emergencies, particularly where 
operative intervention is required, expertise of an ENT 
specialist is necessary 10. Vishwanath M et al. (2014), 
assessed drug utilization pattern among hospitalized 
children. He randomly selected total 150 inpatients aged 1-5 
years admitted in the Paediatric ward for study. 80(53.33%) 
patients were males while 70 (46.67%) females. Age 
distribution showed, most of the patients were between 1-2 
years old with the percentage of 34.67, followed by 4-5 years 
(31.33%) and 2-3 years (25.33%).Respiratory system 
disease (33.33%) was most commonly seen, followed by GIT 
(19.33%) & CNS (16.67%) disorders. Among them 
Pneumonia, Acute GE and Seizure disorder were most 
commonly seen. A total of 854 drugs were prescribed. Most 
commonly prescribed drug classes were antimicrobial 
agents (28.10%), drugs acting on respiratory system 
(12.18%) and NSAIDs (7.50%). Penicillins (28.75%) were 
the most commonly prescribed AMAs, followed by 
aminoglycosides (23.33%) & cephalosporins (17.5%). 
Salbutamol aerosol (48.08%) was the most commonly used 
bronchodilator followed by inhaled salbutamol + 
ipratropium (21.15%) 11. Piromchai P et al (2014), studied 
the impact of treatment time on the survival of patients 
suffering from invasive fungal rhinosinusitis. It was observed 
that more than 70% of the mortalities occurred within the 
subgroup of patients who exhibited symptoms of the 
diseases within 14 days before admission. The study 
concluded that the time taken to treat the patients is an 
important determinant for the survival of patients who are 
afflicted with invasive fungal rhiniosinusitis. The appropriate 
treatments should be administered within 14 days from the 
time the symptoms begin to manifest 12.  Goud KS et al. 
(2014), conducted an observational study to evaluate the 
drug utilization pattern in upper respiratory tract infections 
in out patient department at MGM hospital, Navi Munbai, for 
a period of six months. Results showed that out of 200 URTI 
patients, 132 were males and 628 were females. The total 
numbers of drugs prescribed were 710. The average 
numbers of drugs per prescription were 3.55. total number 
of antibiotics prescribed were 194(27.32%), out of total 
drugs , most commonly prescribed drug was xylometazoline 
16.33%, 69.85% drugs were prescribed as FDC. !00% drugs 
were prescribed by brand names. They concluded that most 
commonly drug combination used was that of paracetamol, 
anhydrase caffeine, phenylephrine, chlorphenireamine 
maleate, nasal decongestants and antihistamines. Frequent 
used of FDC and prescribing by brand names are matter of 
concern 13. Venkateshkaramurthy N et al. (2013), 
conducted study of drug utilization pattern among pediatric 
patients. The mean age of patients whom the prescription 
were written was 95.3 months. Newborn infants (neonates) 
comprised only 2.1% of the total prescriptions. Majority, 
54.5%, of the recipients were males. 29.7% and 68.2% of 
total prescriptions were made to Infants and Toddlers of age 
28 days-23 months and 2-11years, respectively. The study 
showed that most of the drugs were used for conditions like 
fever (34.6%), Respiratory Diseases (21.7%), gastro-
intestinal disorder (16.8%), and infection diseases (12.6%). 
These conditions were most common reason for 
hospitalization of the pediatric patients. Respiratory diseases 
known as Asthma, Chronic Obstructive Pulmonary Disorder 
(COPD), Pneumonia fever and Bronchitis. Gastrointestinal 
disorder known as Acute Gastro enteritis (AGE), Diarrhoea, 
Dehydration and constipation. Anti-infective agents were the 
main class of drugs prescribed [339 (24.8%)]. Other classes 
of commonly prescribed drugs were anti-inflammatory 
agents (20.8%), intravenous fluids (19.0%), and gastro-
intestinal therapy (14.7%). The anti-infective agents were 
mainly used in the inpatient settings. Of the anti-infective 
agents, betalactam antibiotics were most commonly 
prescribed 14. Sam TA et al. (2012), studied the drug 
utilization patterns amongst asthmatic patients of all age 
ranges through retrospective analysis, and to collate the data 
obtained. The most commonly prescribed drug was 
Salbutamol 120 (20.97%), followed by Montelukast 89 
(15.56%) number of medication ad Prednisolone 87 
(15.21%) among the other drugs upon 572 number of 
medication. Salbutamol or albuterol is chosen as the first line 
agent in the management of asthma where they are used as 
required by the patient for the symptomatic relief of 
breathlessness and wheezing. Asthma control and prior 
medical care of patients presenting with acute asthma at the 
emergency department where it showed that salbutamol 
was the most prescribed drugs where fifty-seven (81%) 
patients were using inhaled salbutamol but 21 (30%) were 
still using oral short acting salbutamol. Only 32 (46%) 
patients used inhaled corticosteroids. This is because 
salbutamol does not increase exacerbation rates. The least 
prescribed medications are Dexamethasone 1(0.18%) and 
Ipratropium bromide 1(0.18%) in the context of 
monotherapy. If dexamethasone is given orally or by 
injection (parenteral) over a period of more than a few days, 
side-effects common to systemic glucocorticoids may occur. 
These may include: Stomach upset, increased appetite 
leading to significant weight gain, latent diabetes mellitus 
often becomes manifest. Glucose intolerance is worsened in 
patients with preexisting diabetes. Osteoporosis and 
depression of the adrenal gland is usually seen 15. Gupta AS 
et al. (2012), studied on clinico-epidemiological profile of 
ear, nose and throat diseases among patients aged 6 to 14 
years attending the E.N.T. OPD at M.G.M. Medical College, 
Kishanganj Bihar, India. Among the 639 patients who were 
examined, 281 (43.98%) of children were of the age group of 
6-10yrs and 358 (56.02%) of children were of 11-14 yrs. 
48.36% of children were male and 51.64% were females. 
Around 232 (36.31%) children belong to APL while 407 
(63.69%) of them came from BPL families. About 51.17% 
(327) children were illiterate, 29.89% (191) were studying 
in primary standards and 18.94% (121) children were 
studying in secondary standard. Majority of the children 
were found to be suffering from various Ear, Nose and 
Throat infections. Out of 639 patients, 298 (46.64%) were 
suffering from only ear diseases, 117 (18.30%) were 
suffering from only nose diseases, 77 (12.05%) of them had 
only throat problems, whereas 95 (14.87%) had ear and 
nose problems, 32 (5.01%) had both throat and nose 
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problem and 11 (1.72) of them had ear & throat diseases. 
Rest 9 (1.41%) patients had other problems like foreign 
body (F.B.) in the airway or oesophagus and TB lymph 
nodes. This study indicated that ear, nose and throat 
diseases, especially ear diseases were a considerable burden 
in the Kishanganj district among the school going age group. 
The study revealed that CSOM-safe (37.62%) and CSOM-
unsafe (8.42%) were relatively common 16. Sivakumar P et 
al (2011), carried out a study to highlight the antimicrobials 
prescribing pattern of physicians in ear, nose, throat 
disorders and their relationship in inpatients and 
outpatients. The study was carried over a period of six 
months. The patients treated with antimicrobials were used 
for the study. By using the inclusion and exclusion criteria 
591 were selected (558 patients from OPD and 33 patients 
were from IPD). It was found that 58.54% patients were 
males and majority of the patients (19.29%) were in the age 
group of 26-35 years. Maximum numbers of patients were 
diagnosed with ear infections (38.41%). The most common 
ear disorders were CSOM (37.88%), nasal disorders were 
ARS (56.10%) and the throat disorders were 
Tonsilitis(65.11%). Most commonly prescribed categories of 
antimicrobials were found to be Fluoroquinolones (61.88%). 
Abundant of patients (81.89%) received antimicrobial 
monotherapy. Most of the antimicrobials were administered 
through oral route (73.98%). The mean number of 
antimicrobial agents prescribed per prescription was found 
to be 1.20. Their study highlighted lesser utilization of 
antimicrobials. The majority of the patients were not treated 
in accordance with the current guidelines. The number of 
patients was low and the study was restricted to only one 
hospital, hence the results cannot be considered 
representative of whole country. However, in spite of all 
these limitations, the study highlighted some rational 
prescribing practices. Cost of antibiotics could be one of the 
major contributing factors for non-compliance in a 
developing country like India 17.  Ain MR et al. (2010), 
worked on the prospective studies of drug utilization pattern 
of antibacterials used in ENT outpatients and inpatients. 
Study showed that ENT infection are more prevalent among 
young adults, majority of patients were in the age group of 
16-25 years. Patients suffering from various acute and 
chronic infections were treated with different antibacterials. 
Most commonly prescribed antibacterials include β-lactam 
antibiotics (45.52%), followed by quinolones (26.31%) and 
macrolides (12.12%). Among the individual antibiotics, 
maximum pateints received a combination of amoxicillin 
with clavulinic acid (21.74%) followed by gemifloxacin 
(14.41%), chloramphenicol (9.84%), azithromycin (8.69%), 
cefpodoximeproxetil (5.49%) and doxycycline (3.66%) 18. 
Yadav P et al. (2010) conducted a study on drug utilization 
trends in OPD patients in teaching hospitals. The ENT 
patients constituted 102 (3.42%) of the total patients 
attending the hospital OPD. The analysis of demographic 
data showed that of 102 patients (45) were female and 55 
were man. The topical preparation used were: gentamicin 20 
(5.4%), ciprofloxacin 4 (1.18%), Clotrimazole 2 (0.59%), 
steroid combination drops 9 (2.67%), dexamethasone, 
betamethasone in combination with neomycin, clotrimazole. 
The ear softeners used were usually combination of 
praradichlorobenzene, Benzocaine, turpentine oil 19 
(5.63%). Antiseptic mouth washes were prescribed to 26 
(7.71%) cases. The antiallergics used were Cetrizine 6 
(1.78%), Fexofenadine 7 (2.07%), Loratidine 5 (1.48%), 
Chlorpheniramine 2(0.59%), Pheniramine 1 (0.29%). Many 
preparations contained antihistaminics in combination with 
paracetamol, phenylephrine malelate or pseudoephedrine. 
41(4.15%). The antibiotics commonly prescribed were 
Macrolides 26%, Amoxicillin 14%, Fluroquinolones 12%, 
and Cephalosporin 06%. The Macrolides commonly 
prescribed were Azithromycin and Roxithromycin. 
Sparfloxacin was the common fluroquinolone used. 
Ciprofloxacin was used in 4 cases. Amoxicillin was used 
alone, and incombination with cloxacillin, and Clavulanic 
acid. The cephalosporin’s used were cefuroxime, cefaclor. 
Tinidazole was prescribed in two subjects 19. Panznera P et 
al. (2015), worked on the bronchial inflammation in 
seasonal allergic rhinitis with or without asthma in relation 
to natural exposure to pollen allergens. In 52 patients 
Sputum was induced with seasonal allergic rhinitis without 
asthma, 38patients with seasonal allergic rhinitis and 
seasonal asthma and 23 healthy volunteers. Sampling was 
performed 6-8 weeks before the expected beginning of 
symptoms, during symptomatic period and 6-8 weeks after 
the end of symptoms. Sputum ECP was measured by means 
of chemi-luminiscent immunometric assay and sputum cell 
counts were assessed by classical staining and immune 
cytochemistry. Sputum eosinophils were on the whole higher 
in both asthma and rhinitis compared to controls (p < 0.001, 
p = 0.003). The rise of eosinophils during pollen season 
compared with values out of pollen season was significant in 
asthma (classical staining) (p = 0.014) and slightly apparent 
in rhinitis (immune cytochemistry) (p = 0.073). The seasonal 
rise of sputum ECP was observed only in rhinitis (p = 0.006). 
Inflammation of the lower airway in patients with allergic 
rhinitis with and without asthma has been confirmed by 
means of both sputum eosinophil count and sputum ECP 
level. Persistent inflammation of lower airway in periods 
without allergen exposure was proven in seasonal asthma. 
This may have implications for the therapy of seasonal 
allergic rhinitis with and without asthma in terms of 
promoting long-term anti-inflammatory treatment 20.  Okubo 
K et al. (2014), worked on the Japanese guideline for 
Allergic Rhinitis 2014 like asthma and atopic dermatitis, 
allergic rhinitis is an allergic disease, but of the three, it is the 
only type I allergic disease. Allergic rhinitis includes 
pollinosis, which is intractable and reduces quality of life 
(QOL) when it becomes severe. To understand allergic 
rhinitis and to use this knowledge to develop a treatment 
plan is needed. In Japan, the Japanese Society of Allergology 
in 1993 was prepared the first guideline after a symposium. 
In 2013 the current 7th edition was published, and is widely 
used today. To incorporate evidence based medicine (EBM) 
introduced from abroad, the most recent collection of 
evidence literature was supplemented to the Practical 
Guideline for the Management of Allergic Rhinitis in Japan 
2013. The revised guideline includes assessment of diagnosis 
treatment and prescriptions for children and pregnant 
women, for broad clinical applications. An evidence-based 
step-by-step strategy for treatment is also described. In 
addition, the QOL concept and cost benefit analyses are also 
addressed. Along with Alergic Rhinitis and its Impact on 
Asthma (ARIA), this guideline is widely used for various 
clinical purposes, such as measures for patients with 
sinusitis, childhood allergic rhinitis, oral allergy syndrome, 
and anaphylaxis and for pregnant women. A Q&A section 
regarding allergic rhinitis in Japan was added to the end of 
this guideline 21. Lambert L (2014) worked on the flu or 
allergy. Patients often present at the pharmacy with 
complaints of “flu”. Although flu is a common illness, the 
word “flu” is often used loosely to describe general feelings 
of ill health. However, in many instances, symptoms may be 
confused with those of an allergy. It is important to know 
and understand the difference between influenza and 
allergies such as hay fever, in order to ensure correct 
diagnosis and offer appropriate therapeutic approaches. This 
article will review the clinical manifestations of influenza 
and allergic rhinitis, and highlights the difference between 
these two illnesses 22. Joshi S et al. (2014), Technology and 
social media have dramatically altered the landscape in 
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which we practice medicine. Clinicians have increasingly 
turned to technology and the internet to enhance patient 
care. Allergists have used these modalities to improve 
utilization and adherence to immunotherapy. Electronic 
medical records (EMRs) are being widely adopted by allergy 
practices and some offer allergy/immunology specific 
modules that aid in daily workflow. The development of 
specialized devices that reduce pain associated with 
immunotherapy administration may improve compliance 
with immunotherapy. Social media and other forms of 
electronic communication such as e-mail, Facebook, Twitter, 
short message service (SMS), and YouTube give clinicians 
multiple avenues to disseminate information and reach their 
patients, possibly improving patient adherence to therapy. 
Finally, tablet computers, online networks, and electronic 
surveys provide additional ways to connect patients and 
physicians 23. Honda K et al. (2013), studied on the 
relationship between pollen count levels and prevalence of 
Japanese cedar pollinosis in Northeast Japan. The study 
population consisted of 339 elementary school students (10-
11 years of age) from the coastal and mountainous areas of 
Akita in 2005-2006. A questionnaire about symptoms of 
allergic rhinitis was filled out by the students’ parents. A 
blood sample was taken to determine specific IgE antibodies 
against five common aeroallergens. The mean pollen count in 
the mountainous areas was two times higher than that in the 
coastal areas in 1996-2006. The prevalence rates of nasal 
allergy symptoms and sensitization for mites were almost 
the same in both areas. On the other hand, the rates of nasal 
allergy symptoms and sensitization for JC pollen were 
significantly higher in the mountainous areas than in the 
coastal areas. The rate of the development of symptoms 
among children sensitized for JC pollen was almost the same 
in both areas. These results suggest that pollen count levels 
may correlate with the rate of sensitization for JC pollinosis, 
but may not affect the rate of onset among sensitized 
children in northeast Japan 24. 
CONCLUSION 
ENT problems have been counted as prominent as well as 
commonly occurring medical problem for our society. It is a 
problem of most concern. Drug utilization studies can play a 
major role to identify the nature of therapy used in their 
treatment and also helps to promote the rationality and 
minimizing the errors in the drug therapy. Such kind of 
studies can be helpful for healthcare practitioners as well as 
to the society against such health issues. The demographic 
profile of the population utilizing antibiotics, steroids, anti-
allergic drugs and many more in their prescription for the 
treatment of any type of ENT disorder includes gender-wise 
distribution, age-wise distribution and socioeconomic class 
wise distribution of patients. Drug utilization research 
developed quickly during the last 30 years and soon became 
a respectable subject for consideration at international 
congresses in pharmacology, pharmacy and epidemiology. 
Successful research in drug requires multidisciplinary 
collaboration between clinicians, clinical pharmacologists, 
pharmacists and epidemiologists. Without the support of the 
prescribers, this research effort will fail to reach its goal of 
facilitating the rational use of drugs. 
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